Sfoglia per AUTORE
MELE G
Collezione AOU Novara

  

Items : 3

Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials. in Haematologica / Haematologica. 2024 Jan 1;109(1):245-255. doi: 10.3324/haematol.2023.283251.

2024
AOU Città della Salute di Torino
AOU Novara

Morabito F; Neri A; Di Raimondo F; Petrucci MT; Nappi D; Bertuglia G; Ferretti E; Sgherza N; Rizzi R; Cotzia E; Gozzetti A; Bongarzoni V; Rossini B; Fontana R; Accardi F; Amico V; Amendola A; Vincelli D; Brunori M; Palumbo G; Pompa A; Uccello G; Barilà G; Casaluci GM; Rago A; Ria R; Tarantini G; Offidani M; Cerchione C; et alii...

Effects of daratumumab on hematopoietic stem cell collection and engraftment in multiple myeloma patients eligible for autologous transplantation: results of the real-life PRIMULA study comparing bortezomib, thalidomide and dexamethasone (VTd) with VTd plus daratumumab (D-VTd) as induction therapy. in Annals of hematology / Ann Hematol. 2024 Aug 22. doi: 10.1007/s00277-024-05933-3.

2024
AOU Novara

Tarantini F; Buda G; Rizzi R; Curci P; Attolico I; Carluccio P; Ostuni A; Sgherza N; Strafella V; Del Giudice ML; Marasco V; Mele A; Margiotta-Casaluci G; Valli VB; Mele G; Germano CR; Quinto AM; Palazzo G; Febbo MA; Ciuffreda L; Reddiconto G; Di Renzo N; Cimminiello M; Albano F; Musto P;

Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score. in Bone marrow transplantation / Bone Marrow Transplant. 2018 Apr;53(4):461-473. doi: 10.1038/s41409-017-0051-y. Epub 2018 Jan 12.

2018
AO Alessandria
AOU Novara

Di Nardo E; Saraceni F; Milone G; Pastore D; Specchia G; Lanza F; Codeluppi K; Mele G; Merli F; Capria S; Musto P; Marktel S; Mengarelli A; Ciceri F; Zallio F; Pini M; Moscato T; Martino M; Pioltelli PE; Piccirillo N; Sica S; Nassi L; Gaidano G; Farina L; Corradini P; Poiani M; Pascale SP; Chiarucci M; Nuccorini R; et alii...